125 related articles for article (PubMed ID: 36775198)
1. Changes in plasma soluble urokinase plasminogen activator receptor levels across pregnancy and in relation to hypertensive disorders.
Cowell W; Limaye M; Brukbaker SG; Silverstein JS; Mehta-Lee SS; Kahn LG; Malaga-Dieguez L; Reiser J; Trasande L
Am J Obstet Gynecol MFM; 2023 May; 5(5):100825. PubMed ID: 36775198
[No Abstract] [Full Text] [Related]
2. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
[TBL] [Abstract][Full Text] [Related]
3. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
[TBL] [Abstract][Full Text] [Related]
4. Irregularities of Coagulation in Hypertension.
Rafaqat S; Khalid A; Riaz S; Rafaqat S
Curr Hypertens Rep; 2023 Oct; 25(10):271-286. PubMed ID: 37561240
[TBL] [Abstract][Full Text] [Related]
5. Elevated preoperative suPAR is a strong and independent risk marker for postoperative complications in patients undergoing major noncardiac surgery (SPARSE).
Chalkias A; Laou E; Kolonia K; Ragias D; Angelopoulou Z; Mitsiouli E; Kallemose T; Smith-Hansen L; Eugen-Olsen J; Arnaoutoglou E
Surgery; 2022 Jun; 171(6):1619-1625. PubMed ID: 34736789
[TBL] [Abstract][Full Text] [Related]
6. [Expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in synovial fluid of patients with temporomandibular disorders].
Hu L; Liang XH; Zhu GQ; Hu J; Shi ZD
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):160-3. PubMed ID: 18788551
[TBL] [Abstract][Full Text] [Related]
7. Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
Rasmussen LJH; Ladelund S; Haupt TH; Ellekilde GE; Eugen-Olsen J; Andersen O
Crit Care Med; 2018 Dec; 46(12):1961-1968. PubMed ID: 30247244
[TBL] [Abstract][Full Text] [Related]
8. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
[TBL] [Abstract][Full Text] [Related]
9. Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China.
Qin DD; Song D; Huang J; Yu F; Zhao MH
Lupus; 2015 May; 24(6):546-57. PubMed ID: 25411257
[TBL] [Abstract][Full Text] [Related]
10. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.
Jensen MK; Riisbro R; Holten-Andersen MN; Brown Pde N; Junker P; Brünner N; Hasselbalch HC
Eur J Haematol; 2003 Oct; 71(4):276-82. PubMed ID: 12950237
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome].
Wu XL; Yu L; Long D; Yang JH; Zhang YC; Geng F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):478-81. PubMed ID: 21878172
[TBL] [Abstract][Full Text] [Related]
12. Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease.
Yeh YH; Wang PH; Lin LY; Tee YT; Chou MC; Yang SF; Tsai HT
Clin Chim Acta; 2013 Jan; 415():138-44. PubMed ID: 23117033
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
Guan YM; Carlberg M; Bruse C; Carlström K; Bergqvist A
Acta Obstet Gynecol Scand; 2002 May; 81(5):389-97. PubMed ID: 12027810
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
Aref S; El-Sherbiny M; Mabed M; Menessy A; El-Refaei M
Hematology; 2003 Dec; 8(6):385-91. PubMed ID: 14668033
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
16. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
Schuettfort VM; Pradere B; D'Andrea D; Grossmann NC; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Karakiewicz PI; Motlagh RS; Katayama S; Lotan Y; Scherr D; Abufaraj M; Fajkovica H; Compérat E; Enikeev D; Shariat SF
J Urol; 2021 Nov; 206(5):1122-1131. PubMed ID: 34181469
[TBL] [Abstract][Full Text] [Related]
18. [Urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in the seminal plasma and sperm of fertile and oligoasthenozoospermia males].
Wang L; Guan HT; Tian YH; Xiong CL
Zhonghua Nan Ke Xue; 2006 Sep; 12(9):791-3. PubMed ID: 17009528
[TBL] [Abstract][Full Text] [Related]
19. Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity.
Ninomiya H; Hasegawa Y; Nagasawa T; Abe T
Int J Hematol; 1997 Apr; 65(3):285-91. PubMed ID: 9114600
[TBL] [Abstract][Full Text] [Related]
20. Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child.
Kemper MJ; Wei C; Reiser J
Am J Kidney Dis; 2013 Feb; 61(2):352. PubMed ID: 23182533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
